|Nom||Titre||Payer||Exercé||Année de naissance|
|Mr. Ivan Tornos||COO, President, CEO & Director||2,05M||S.O.||1975|
|Mr. Suketu P. Upadhyay||CFO and Executive VP of Finance, Operations & Supply Chain||1,81M||S.O.||1969|
|Mr. Chad F. Phipps||Senior VP, General Counsel & Secretary||1,23M||2,77M||1972|
|Mr. Sang Yi||President of Asia Pacific||1,36M||S.O.||1962|
|Mr. Paul A. Stellato||VP, Controller & Chief Accounting Officer||S.O.||S.O.||1975|
|Dr. Nitin Goyal M.D.||Chief Science, Technology & Innovation Officer||S.O.||S.O.||S.O.|
|Mr. Zeeshan Tariq||Senior VP & Chief Information Officer||S.O.||S.O.||S.O.|
|Ms. Keri P. Mattox||SVP and Chief Communications & Administration Officer||S.O.||S.O.||S.O.|
|Mr. Zachary Ross Weiner CPA||Director of Investor Relations||S.O.||S.O.||S.O.|
|Ms. Angela Main||Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific||S.O.||S.O.||S.O.|
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
L’ISS Governance QualityScore de Zimmer Biomet Holdings, Inc. en date du 28 novembre 2023 est 7. Les scores principaux sont Audit : 2; Société : 8; Droits des actionnaires : 4; Compensation : 10.